242 related articles for article (PubMed ID: 37744065)
1. Synthesis,
Alam W; Khan H; Saeed Jan M; Rashid U; Abusharha A; Daglia M
Front Chem; 2023; 11():1222047. PubMed ID: 37744065
[TBL] [Abstract][Full Text] [Related]
2. A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior.
Solidoro R; Miciaccia M; Bonaccorso C; Fortuna CG; Armenise D; Centonze A; Ferorelli S; Vitale P; Rodrigues P; Guimarães R; de Oliveira A; da Paz M; Rangel L; Sathler PC; Altomare A; Perrone MG; Scilimati A
Eur J Med Chem; 2024 Feb; 266():116135. PubMed ID: 38219659
[TBL] [Abstract][Full Text] [Related]
3. Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors.
Yousuf M
Curr Cancer Drug Targets; 2019; 19(11):906-918. PubMed ID: 30894110
[TBL] [Abstract][Full Text] [Related]
4. Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies.
El-Shoukrofy MS; Abd El Razik HA; AboulWafa OM; Bayad AE; El-Ashmawy IM
Bioorg Chem; 2019 Apr; 85():541-557. PubMed ID: 30807897
[TBL] [Abstract][Full Text] [Related]
5. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Novel Aryl (4-Aryl-1H-Pyrrol-3-yl) (Thiophen-2-yl) Methanone Derivatives: Molecular Modelling, In Silico ADMET, Anti-Inflammatory and Anti-Ulcer Activities.
Pasha A; Mondal S; Panigrahi N
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):182-195. PubMed ID: 33200699
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Anti-Proliferative, Anti-microbial, Anti-Angiogenic Activity and
Ünver H; Berber B; Demirel R; Koparal AT
Anticancer Agents Med Chem; 2019; 19(13):1658-1669. PubMed ID: 30887930
[TBL] [Abstract][Full Text] [Related]
8. Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents.
Ahmed EA; Mohamed MFA; Omran OA
RSC Adv; 2022 Sep; 12(39):25204-25216. PubMed ID: 36199335
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in silico molecular docking analysis, pharmacokinetic properties and evaluation of antibacterial and antioxidant activities of fluoroquinolines.
Fekadu M; Zeleke D; Abdi B; Guttula A; Eswaramoorthy R; Melaku Y
BMC Chem; 2022 Jan; 16(1):1. PubMed ID: 35027086
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
11. New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studies.
Darwish SA; El-Kerdawy MM; Elsheakh AR; Abdelrahman RS; Shaldam MA; Abdel-Aziz HA; Hassan GS; Ghaly MA
Bioorg Chem; 2022 Mar; 120():105644. PubMed ID: 35121552
[TBL] [Abstract][Full Text] [Related]
12. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Anti-Inflammatory Activity of Some Coumarin Schiff Base Derivatives: In silico and in vitro Study.
Hamid SJ; Salih T
Drug Des Devel Ther; 2022; 16():2275-2288. PubMed ID: 35860526
[TBL] [Abstract][Full Text] [Related]
14. Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition.
Rahman MM; Junaid M; Hosen SMZ; Mostafa M; Liu L; Benkendorff K
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770946
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors.
Hawash M; Jaradat N; Abualhasan M; Şüküroğlu MK; Qaoud MT; Kahraman DC; Daraghmeh H; Maslamani L; Sawafta M; Ratrout A; Issa L
BMC Chem; 2023 Mar; 17(1):11. PubMed ID: 36879343
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
Bitew M; Desalegn T; Demissie TB; Belayneh A; Endale M; Eswaramoorthy R
PLoS One; 2021; 16(12):e0260853. PubMed ID: 34890431
[TBL] [Abstract][Full Text] [Related]
17. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
18. Design, in Silico Studies and Biological Evaluation of New Chiral Thiourea and 1,3-Thiazolidine-4,5-dione Derivatives.
Evyapan S; Oruç-Emre EE; Sıcak Y; Karaküçük-İyidoğan A; Yılmaz GT; Öztürk M
Chem Biodivers; 2023 Aug; 20(8):e202300626. PubMed ID: 37477542
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological assessment and
Badawy MAS; Abdelall EKA; El-Nahass ES; Abdellatif KRA; Abdel-Rahman HM
RSC Adv; 2021 Aug; 11(44):27659-27673. PubMed ID: 35480694
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies.
Al-Adhreai A; ALSaeedy M; Alrabie A; Al-Qadsy I; Dawbaa S; Alaizeri ZM; Alhadlaq HA; Al-Kubati A; Ahamed M; Farooqui M
Heliyon; 2022 Jun; 8(6):e09746. PubMed ID: 35800717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
